Ex-Celgene dealmaker George Golumbeski joins up to guide Carrick on its cancer drug quest — and maybe an IPO as well
Dublin-based Carrick Therapeutics has picked up a clinical stage cancer drug, as well as a well-connected new chairman of the board.
Ex-Celgene dealmaker George Golumbeski has added to his considerable range of activities by taking the chair at Carrick, which hit the scene two years ago with a $95 million startup round and plans to scoop up a pipeline through a series of partnering deals.
Speaking of which.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.